← Back to catalogue

LeukoStrat

FDA UDI

Class III (US FDA UDI)

by Invivoscribe, Inc.

Identity

Trade Name
LeukoStrat FDA UDI
Generic Name
Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) FDA UDI
Device Name
The LeukoStrat CDx FLT3 Mutation Assay is a PCR-based in vitro diagnostic test designed to detect internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations D835 and I836 in the FLT3 gene in genomic DNA extracted from mononuclear cells obtained from peripheral blood or bone marrow aspirates of patients diagnosed with acute myelogenous leukemia (AML). FDA UDI
Model / Reference
00810022732571 FDA UDI
Description
The LeukoStrat CDx FLT3 Mutation Assay is a PCR-based in vitro diagnostic test designed to detect internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations D835 and I836 in the FLT3 gene in genomic DNA extracted from mononuclear cells obtained from peripheral blood or bone marrow aspirates of patients diagnosed with acute myelogenous leukemia (AML). FDA UDI

Identifiers

Catalog Number
K4120361 FDA UDI
Primary DI / UDI-DI
00810022732571 FDA UDI
PMA Number
P160040 FDA UDI
FDA Product Code
OWD FDA UDI
GMDN Term
Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class III FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT)

LeukoStrat by Invivoscribe, Inc. — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Invivoscribe, Inc.

Sources (1)

  • FDA UDI b3e2403b-7a59-40cf-a459-48ed2ae58ea5 35 fields · synced May 30, 2026